Similar articles

• [Sz-488, a new drug for the treatment of atherosclerosis. Theophylline derivatives 3].

  Harsányi K, Szebeni R, Korbonits D. Harsányi K, et al. Acta Pharm Hung. 1973 Sep;43(5):235-8. Acta Pharm Hung. 1973. PMID: 4755758 Hungarian. No abstract available.
• [Arteriosclerosis with special reference to anticholesteremic agents].

  Murakami M, Sekimoto H, Nakada I, Takegoshi T, Iwaki N. Murakami M, et al. Naika. 1970 Jun;25(6):1082-6. Naika. 1970. PMID: 5431239 Japanese. No abstract available.
• [Pharmacologic therapy of atherosclerosis (I). Current possibilities].

  Segarra Domènech J, Santafé Oroz J. Segarra Domènech J, et al. Med Clin (Barc). 1983 Nov 26;81(17):775-83. Med Clin (Barc). 1983. PMID: 6361403 Review. Spanish. No abstract available.
• [Clinical and therapeutic evaluation of simfibrate compared toclofibrate in atherosclerotic patients].

  De Rosa G, Savi L, De Rosa E, Pola P, Boni P. De Rosa G, et al. Clin Ter. 1979 Feb 15;88(3):267-79. Clin Ter. 1979. PMID: 376218 Clinical Trial. Italian. No abstract available.
• [Pharmacologic therapy of arteriosclerosis. II. New directions].

  Santafé Oroz J, Segarra Domènech J. Santafé Oroz J, et al. Med Clin (Barc). 1985 Jan 26;84(3):115-22. Med Clin (Barc). 1985. PMID: 3919229 Review. Spanish. No abstract available.